These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5988706)

  • 1. [The combination of corticoids, spironolactone, salidiuretics and mannitol according to a particular schema of treatment of ascitic cirrhosis].
    Colucci CF
    Schweiz Med Wochenschr; 1966 May; 96(20):660-5. PubMed ID: 5988706
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prolonged treatment of ascitic cirrhosis by the combination of a saldiuretic and a spironolactone].
    Tolot F; Dechavannes M; Fiere D
    Lyon Med; 1966 Jan; 215(1):29-35. PubMed ID: 5904663
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current treatment of the edematous ascitic syndrome in alcoholic liver cirrhosis].
    Savoye B; Gayet C
    J Med Lyon; 1969 Dec; 50(177):1831-41. PubMed ID: 5374238
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of intravenous mannitol in mobilization of resistant cirrhotic ascites.
    Raza MA; Qureshi UF; Humayoun MA; Waseem T; Akram J
    Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):184-8. PubMed ID: 21183857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory ascites: can it be defined only by the response to furosemide and spironolactone?
    Kalambokis G; Tsianos EV
    Liver Int; 2010 Oct; 30(9):1394; author reply 1395-6. PubMed ID: 20738777
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of diuretic drugs used in cirrhotic and ascitic patients].
    Lennhoff M; Duhalt R; Peña JC
    Rev Invest Clin; 1968; 20(2):165-80. PubMed ID: 5721631
    [No Abstract]   [Full Text] [Related]  

  • 7. High doses of spironolactone in the treatment of liver cirrhosis with ascites.
    Papadoyanakis N; Darsinos J; Alexandrou K; Karli J
    Br J Clin Pract; 1972 Jan; 26(1):27-32. PubMed ID: 5025912
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of cirrhosis with ascites by corticoids].
    Vesin
    Clinique (Paris); 1965 Oct; 60(612):647-8. PubMed ID: 5858996
    [No Abstract]   [Full Text] [Related]  

  • 9. [THE CURRENT TREATMENT OF CIRRHOTIC ASCITES].
    CONTE M
    Presse Med (1893); 1964 Jun; 72():1725-8. PubMed ID: 14154051
    [No Abstract]   [Full Text] [Related]  

  • 10. [The action of glucocorticoids and saluretics on the glomerular filtration and plasma volume in ascitic cirrhosis].
    Vesin P; Traverso H; Roberti A
    Schweiz Med Wochenschr; 1965 Aug; 95(35):1157-60. PubMed ID: 5843807
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of diuretics on the survival of 180 patients with cirrhosis of the liver and ascites].
    Robert M; Portmann B
    Schweiz Med Wochenschr; 1969 Feb; 99(6):178-82. PubMed ID: 5781367
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of triamterene in combination with other diuretics in liver cirrhosis].
    Polli E
    Minerva Med; 1963 Oct; 54(81 Suppl):3018-23. PubMed ID: 5877333
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts].
    Vesin P
    Schweiz Med Wochenschr; 1971 Mar; 101(11):398-401. PubMed ID: 5558553
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, double-blind, placebo-controlled study.
    Ginès P; Wong F; Watson H; Terg R; Bruha R; Zarski JP; Dudley F;
    Aliment Pharmacol Ther; 2010 Apr; 31(8):834-45. PubMed ID: 20102356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and biochemical study of the therapeutic effect of the diuretic triamterene in ascitogenic cirrhosis].
    Păunescu-Podanu A; Demirian H; Ionitã C; Georgescu D; Tarachiu A; Anghel R; Rubingher L
    Med Interna (Bucur); 1968 May; 20(5):523-30. PubMed ID: 5735425
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].
    Grassi V; Porcellati C; Corea L; Todisco T
    Minerva Nefrol; 1968; 15(4):258-60. PubMed ID: 5745815
    [No Abstract]   [Full Text] [Related]  

  • 17. [Triamterene in the treatment of liver cirrhosis with ascites].
    Rodes J; Bosch J; Arroyo V; Nicolau I; Teres J; Bruguera M
    Rev Clin Esp; 1972 Dec; 127(6):1101-8. PubMed ID: 4663288
    [No Abstract]   [Full Text] [Related]  

  • 18. Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites.
    Yamada S; Reynolds TB
    Gastroenterology; 1970 Dec; 59(6):833-41. PubMed ID: 5486268
    [No Abstract]   [Full Text] [Related]  

  • 19. THE MANAGEMENT OF ASCITES.
    SMITH AN; MCMANUS J
    Rev Surg; 1964; 21():1-16. PubMed ID: 14106700
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contribution to the study of the treatment of the ascitic syndrome of cirrhosis by the combination of spironolactone and sulfonamide diuretic. Initial therapy and supportive therapy. Apropos of 55 cases].
    Fraisse H; Perret M; Etaix JP
    J Med Lyon; 1967 Feb; 48(114):173-83. PubMed ID: 5600100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.